Collection of Samples USOPTIVAL Study
Universal Diagnostics · NCT04792684
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 45–84 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1300
- US sites recruiting
- 4
- Study start
- December 30, 2020
- Record last updated
- November 10, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
A prospective multi-center observational study. The study will enroll eligible subjects from the United States to optimize the biomarker panel and evaluate the performance of a cfDNA marker panel selected by the Sponsor for CRC and advanced adenoma detection.
Being studied: Optimization of Plasma Circulating Free-DNA (cfDNA) Marker Panel
Conditions: Colorectal Cancer (CRC); Advanced Adenomas (AA)
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Arm A
- Must be 45-84 years of age.
- Must have a suspected advanced adenoma or be newly diagnosed with CRC, still not resected, and scheduled for surgery.
- Able to comprehend, sign, and date the written informed consent document.
Arm B
- Must be 45-84 years of age.
- Able and willing to undergo a standard-of-care screening colonoscopy within 60 days.
- Able to comprehend, sign, and date the written informed consent document.
Exclusion Criteria
Arm A Only
- Subject with curative biopsy during colonoscopy.
Arm B Only
- Subjects with positive FIT Test results in the 6 months preceding enrollment.
- Subject has a current diagnosis of cancer.
Arms A \& B:
- Subject has a personal history of aerodigestive or digestive tract cancers.
- Subjects having undergone previous partial surgical removal of one or more portions of their colon due to a reason other than colorectal cancer.
- Has a known diagnosis or personal history of any of the following high-risk indications for colorectal cancer:
- Inflammatory bowel disease (IBD) including chronic ulcerative colitis (CUC) and Crohn's disease.
- Familial adenomatous polyposis ("FAP", including attenuated FAP).
- Hereditary non-polyposis colorectal cancer syndrome ("HNPCC" or "Lynch Syndrome").
- Serrated polyposis syndrome
- 2 first-degree relatives (e.g., parents, siblings, and offspring) who have been diagnosed with colon cancer.
- One first-degree relative with CRC diagnosed before the age of 60.
- A significant disease which, in the Investigator's opinion, would exclude the subject from the study.
- Legal incapacity or limited mental capacity.
- Medical or psychological conditions that would not permit the subject to complete the study or sign informed consent.
- The patient has a known or documented previous or current medical history of infectious diseases that can be transmitted through blood (E.g. Hepatitis, HIV, etc.), including patients that have been treated, are currently being treated, or have not been treated for that conditions.
- The patient is known to be pregnant when recruited or during her participation in the study.
Recruiting US locations
Lakeland Regional Cancer Center
Lakeland, FL 33805
Site contact: Manuel Molina
Springfield Clinic
Springfield, IL 62702
Site contact: Peter Hofmann
Mid Hudson Medical Research
New Windsor, NY 12553
Site contact: Sashi Makam
University of Pennsylvania
Philadelphia, PA 19104
Site contact: Bryson Katona
Study contacts (from the official record)
- Antonio Jesus Merino Calvo · (+34)674945571 · antonio.merino@universaldx.com
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65